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primary adult grey and white matter
astrocytes underlie differences in
modulation of in vitro myelination
Inge L. Werkman1, Marissa L. Dubbelaar1, Pieter van der Vlies2, Jelkje J. de Boer-Bergsma2, Bart J. L. Eggen1 and
Wia Baron1*
Abstract
Background: Multiple sclerosis (MS) is an inflammation-mediated demyelinating disease of the central nervous
system that eventually results in secondary axonal degeneration due to remyelination failure. Successful
remyelination is orchestrated by astrocytes (ASTRs) and requires sequential activation, recruitment, and maturation
of oligodendrocyte progenitor cells (OPCs). In both MS and experimental models, remyelination is more robust in
grey matter (GM) than white matter (WM), which is likely related to local differences between GM and WM lesions.
Here, we investigated whether adult gmASTRs and wmASTRs per se and in response to MS relevant Toll-like
receptor (TLR) activation differently modulate myelination.
Methods: Differences in modulation of myelination between adult gmASTRs and wmASTRs were examined using
an in vitro myelinating system that relies on a feeding layer of ASTRs. Transcriptional profiling and weighted gene
co-expression network analysis were used to analyze differentially expressed genes and gene networks. Potential
differential modulation of OPC proliferation and maturation by untreated adult gmASTRs and wmASTRs and in
response to TLR3 and TLR4 agonists were assessed.
Results: Our data reveal that adult wmASTRs are less supportive to in vitro myelination than gmASTRs. WmASTRs
more abundantly express reactive ASTR genes and genes of a neurotoxic subtype of ASTRs, while gmASTRs have
more neuro-reparative transcripts. We identified a gene network module containing cholesterol biosynthesis
enzyme genes that positively correlated with gmASTRs, and a network module containing extracellular matrix-
related genes that positively correlated with wmASTRs. Adult wmASTRs and gmASTRs responding to TLR3 agonist
Poly(I:C) distinctly modulate OPC behavior, while exposure to TLR4 agonist LPS of both gmASTRs and wmASTRs
results in a prominent decrease in myelin membrane formation.
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Conclusions: Primary adult gmASTRs and wmASTRs are heterogeneous at the transcriptional level, differed in their
support of in vitro myelination, and their pre-existing phenotype determined TLR3 agonist responses. These
findings point to a role of ASTR heterogeneity in regional differences in remyelination efficiency between GM and
WM lesions.
Keywords: Astrocytes, Multiple sclerosis, Myelination, Oligodendrocyte, Region
Background
Remyelination is a natural regenerative process that oc-
curs after demyelination, to form new myelin mem-
branes around denuded axons. In the central nervous
system (CNS), remyelination is executed by oligodendro-
cytes (OLGs) and involves activation, recruitment, and
differentiation of oligodendrocyte progenitor cells
(OPCs) into mature, myelinating OLGs [1]. Remyelina-
tion is orchestrated by transient signaling of reactive
astrocytes (ASTRs) [2, 3]. Similar as during CNS devel-
opment [4], ASTRs support oligodendrocytes and myelin
membrane formation by extracellular matrix (ECM) re-
modeling [5, 6] and the supply of fatty acids and choles-
terol [4, 7, 8]. Upon demyelination, ASTR reactivity is
induced by a variety of inflammatory mediators such
as Toll-like receptor (TLR)ligands [9–13] as well as
by myelin debris, and includes changes in ASTR morph-
ology, gene expression, and function [14–19]. ASTR re-
activity can be beneficial or detrimental for
remyelination [2, 12, 20, 21], as ASTR responses toward
injury vary and depend on the type of injury. In this re-
gard, two subtypes of injury-dependent reactive ASTRs
have been described; neuro-inflammation-induced A1-
ASTRs and ischemia-induced A2-ASTRs [14, 22]. A1-
ASTRs possess a neurotoxic phenotype and secrete fac-
tors that inhibit OPC proliferation, migration, and differ-
entiation, and that are toxic to mature OLGs [22]. By
contrast, A2-ASTRs appear more neuroprotective and
more supportive toward repair [22]. Although the classi-
fication of ASTR reactivity into A1-ASTRs and A2-
ASTRs is very useful as a concept, it is clear that add-
itional injury-dependent astrocyte reactivity states exist
[23]. Also at homeostatic conditions, ASTRs are not uni-
form, and multiple studies have described ASTRs diver-
sity based on their morphology, gene expression, and
function [22, 24–30].
Historically, ASTRs are divided into two groups; fi-
brous ASTRs that mainly reside in the white matter
(WM) and the morphologically more complex proto-
plasmic ASTRs that are present in the grey matter (GM)
[27, 31, 32]. Multiple single-nucleus RNA sequencing
studies identify two to three clear distinct groups of
ASTRs dispersed throughout adult GM and WM [29,
33–35], while morphological and functional studies
identify up to nine different groups of ASTRs in rodents
[25, 36]. ASTR reactivity is also region-dependent, i.e.,
upon cuprizone-induced demyelination, ASTRs reactiv-
ity is evident earlier in the cortex, a GM area, than the
corpus callosum, a WM area, but ASTR reactivity is
more extensive in ASTRs of the corpus callosum [19,
37–39]. Furthermore, demyelination is delayed in the
cortex compared to the corpus callosum [38], and
remyelination occurs faster in GM than in WM areas
[37]. Also, in the chronic demyelinating disease multiple
sclerosis (MS), remyelination is more efficient in GM
than in WM [40, 41], but ultimately fails in both areas,
contributing to disease progression [1, 42, 43]. As in
toxin-induced demyelination rodent models, ASTR re-
activity differs between GM and WM MS lesions.
Hypertrophic ASTRs form a glial scar in and around in-
flammatory WM lesions, but not around lesions in the
GM [12, 15, 44, 45]. This difference in ASTR reactivity
may contribute to the more efficient remyelination in
GM MS lesions [3, 37, 41, 46]. In addition, neurotoxic
A1-ASTRs are present in WM MS lesions [22], while
the presence of A1-ASTRs in GM MS lesions has not
been analyzed yet. It is currently not clear whether in-
trinsic differences between gmASTRs and wmASTRs
contribute to regional differences in ASTR reactivity
and/or whether they differently respond to the same
type of injury and inflammation. By performing tran-
scriptional profiling and the use of an in vitro myelinat-
ing system that depend on ASTRs, we addressed here
whether adult gmASTRs and wmASTRs are different
cell populations that distinctly modulate myelination. In
addition, as innate TLR-mediated signaling plays a role
in MS pathology [47–50], we assessed whether
gmASTRs and wmASTRs display a differential response
to TLR3 and TLR4 agonists. Our findings revealed that
adult wmASTRs and gmASTRs display transcriptional





Adult astrocytes (ASTRs) were isolated from young
adult female Wistar rats brains via a non-shake off pro-
cedure as described [51], with minor modifications. To
obtain gmASTRs, the cerebral cortices were dissected
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and meninges removed. Of the residual non-cortex tis-
sue, the amygdala was discarded and the remaining non-
cortical regions (WM tracts including corpus callosum,
mixed GM and WM tracts, including hippocampus and
thalamus, and deep GM parts, including basal ganglia)
were kept in HBSS. Although the dissected non-cortical
ASTRs contain gmASTRs, they mainly consist of
wmASTRs and were therefore referred to as wmASTRs.
Brain tissue was kept in Hank’s balanced salt solution
(HBSS, Life Technologies) and mechanically dissected
using scissors. Then, 0.05% trypsin (Sigma) and 0.003%
DNase (Roche) in 1 mL HBSS was added and incubated
for 15 min at 37 °C, followed by centrifugation for 7 min
at 400 g. The pellet was resuspended in papain digestion
mix [24 μg/mL L-cysteine (Sigma), 40 μg/mL DNase I,
30 U/mL papain from papaya latex (Sigma) in MEM
(Life Technologies)] incubated for 15 min at 37 °C. The
digestion was stopped using OVO [40 μg/mL DNase I, 1
mg/mL soybean trypsin inhibitor (Sigma), 50 μg/mL bo-
vine serum albumin (BSA, Sigma) in Leibowitz L-15
medium (Sigma)] for 6 min at room temperature. The
cell suspension was centrifuged for 7 min at 400 g and
resuspended in 15 mL HBSS. Hereafter, the cells were
settled for 30 min before the upper layer was separated
from the lower cell fraction. The cell fractions were di-
luted in 15 mL HBSS and centrifuged for 7 min at 400
g. Cell pellets were resuspended in AA+ medium [10%
fetal bovine serum (FBS), 15 mM Hepes (Gibco), 0.04%
gentamicin (Life Technologies), 14.3 mM NaHCO3
(Merck), 100 U/mL penicillin, 100 μg/mL streptomycin,
4 mM L-glutamine]. The cells were cultured for 20 days
at 37 °C in tissue flasks (Nunc T80; Thermo Fisher Sci-
entific) that were coated with poly-L-lysine (PLL, 5 μg/
mL, Sigma). Medium exchange occurred once every 3–4
days. The cells were passaged at least once using trypsin
and used for experiments after 2–3 weeks, or collected
in RNA protect (Qiagen) for 3′-RNA sequencing. To ob-
tain ASTR-conditioned medium (ACM), ASTRs were
cultured for 24 h either untreated or in the presence of
50 μg/mL TLR3 agonist polyinosine-polycytidylic acid
(Poly(I:C), Sigma) or 200 ng/mL TLR4 agonist lipopoly-
saccharide (LPS, Sigma), after which cells were washed
and cultured for another 24 h in defined SATO medium
[5 μg/mL bovine insulin (Sigma), 50 μg/mL human
holo-transferrin (Sigma), 100 μg/mL BSA fraction V
(Sigma), 62 ng/mL progesterone (Sigma), 16 μg/mL pu-
trescine (Sigma), 5 ng/mL sodium selenite (Sigma), 400
ng/mL T3 (Sigma), 400 ng/mL T4 (Sigma), 4 mM L-glu-
tamine, 100 U/mL penicillin and streptomycin]. Here-
after, ACM was collected and filtered using a 0.45 μm
filter, to remove cell debris. To obtain ASTR extracellu-
lar matrix (ECM), ASTRs were cultured for 48 h either
untreated or in the presence of Poly(I:C) or LPS, after
which cells were lysed by water (two times 1 h, cell lysis
was checked by a microscope) and ECM was scraped in
sterile PBS containing a cocktail of protease inhibitors
(Complete, Roche). Notably, adult gmASTRs and
wmASTRs were always generated at the same time from
the same animal and cultured at similar conditions.
Oligodendrocyte progenitor cells
Oligodendrocyte progenitor cells (OPCs) were isolated
from mixed glia cultures of the cortex of newborn rat
forebrains using a shake-off procedure as described [52–
54]. Briefly, contaminating microglia were removed from
the flask by a pre-shake on an orbital shaker (Innova
4000, New Brunswick) at 150 rpm for 1 h at 37 °C and
OPCs were obtained after a shake at 240 rpm for 20–22
h at 37 °C. The detached OPCs were further purified by
differential adhesion on non-tissue dishes [54]. The
enriched OPC cultures contained 95–97% OPCs (Olig2-
positive), 1–3% astrocytes (GFAP-positive), and less than
1% microglia (IB4-positive) and neurons (TuJ1-positive).
The OPCs were cultured on PLL-coated 13-mm cover-
slips (35,000 cells/coverslip) or on ECM-coated 8-well
Permanox chamber slides (8 μg of ECM/chamber 28,000
cells/chamber). For proliferation, OPCs were cultured for
24 h in defined SATO medium containing 10 ng/mL
platelet-derived growth factor-AA (PDGF-AA, Peprotech)
and 10 ng/mL fibroblast growth factor-2 (FGF2, Pepro-
tech) in the presence or absence of ACM (diluted 1:1). For
other assays, cells were cultured for 2 days in SATO
medium supplemented with PDGF-AA and FGF2,
followed by differentiation upon growth factor withdrawal
and culturing for 6 days in SATO supplemented with
0.5% FBS. Cells were cultured in the presence or absence
of ACM (diluted 1:1) or on ECM coatings, after which dif-
ferentiation, myelin membrane formation, and metabolic
activity were determined.
Spinal cord cultures
Myelinating spinal cord cultures that rely on a mono-
layer of feeding ASTRs were generated from 17-day-old
Wistar rat embryos as described with minor modifica-
tions [55]. Meninges were removed from the dissected
spinal cord, and mechanical dissociation of the tissue
was performed in ΜΕΜ. Hereafter, the tissue was enzy-
matically digested with a mixture of trypsin (2.5%,
Sigma) and liberase DH (2.5 mg/mL, Roche) for 20 min
at 37 °C. The enzymatic reaction was stopped by
addition of Soybean trypsin inhibitor solution [0.52 mg/
mL soybean trypsin inhibitor (Sigma), 40 μg/mL DNase
(Roche), and 3 mg/mL BSA fraction V in Leibovitz’s L15
medium]. After centrifugation for 7 min at 220 g, cells
were resuspended in plating medium consisting of 50%
DMEM (1500 mg/L glucose, Gibco), 25% horse serum
(Invitrogen), 25% HBSS with calcium and magnesium
(Gibco), and 2 mM L-glutamine (Invitrogen). The total
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spinal cord cell suspension was plated at a density of
200,000 cells/well in a 24-wells containing a 2-day-old
confluent feeding layer of adult gmASTRs or wmASTRs
(120,000 cells/24 well) in 500 μL plating medium. When
cells were attached, 500 μL growth medium [DMEM
(4500 mg/L glucose, Gibco) supplemented with 5 mg/
mL holotransferin (Sigma), 20 mM putrescine (Sigma), 4
μM progesterone (Sigma), 6 μM selenium (Sigma), 10
ng/mL biotin (Sigma), 50 nM hydrocortisone (Sigma),
and 10 μg/mL insulin (Sigma)] was added. Every 2–3
days, half of the medium was replaced with new growth
medium. Insulin was omitted from growth medium after
12 days in culture and cultures were analyzed at 26–30
days in culture.
Gene expression and WGCNA
RNA was isolated using the RNeasy Plus Micro Kit
(QIAGEN) and RNA quality was assessed using a
BioRad Experion Highsense RNA kit according to manu-
facturer’s instructions. All RIN-values were higher than
7.9. Library preparation was performed with the Lexogen
QuantSeq 3′mRNA-Seq Library Prep kit for Ilumina ac-
cording to manufacturer’s instructions. All samples were
pooled and sequenced on the Illumina NexSeq 500. Data
was processed using the pipelines that were provided by
MOLGENIS (https://github.com/molgenis). Quality con-
trol of the data was performed on the raw fastq files with
fastQC (0.11.3). Next, HiSat (0.1.5) was used for align-
ment of the sequenced reads against the Rattus norvegi-
cus genome (38.82) allowing 2 mismatches, and the
aligned data was sorted with samtools (1.2). Finally,
HTSeq (0.6.1p1) was used to quantify the data using the
parameters: --stranded=no and --mode=union. High and
low expressed genes were distinguished using the Data-
adaptive flag method for RNA-sequencing (DAFS).
Normalization and processing of the raw reads were per-
formed with EdgeR (3.20.9). To determine differentially
expressed genes, an absolute logarithm of the fold
change (logFC) of more than 2 and an FDR < 0.01 were
used. Volcano plots were made using the ggplot2 pack-
age. The DAFS filtered genes were used as input to
generate a signed network (with a soft power of 10) with
the topological overlap matrix (TOM) function (TOMsi-
milarity). Cutting of the hierarchical clustered TOM
with the function cutreeDynamic with a minimum clus-
ter size of 100 and cutHeight 0.99 was used to determine
the different modules. Afterward, similar gene expres-
sion modules were merged with mergeCloseModules
(cutHeight 0.25). In the end, userListEnrichment was
used to identify possible traits of the identified modules
where the grey lists were omitted, with enabling of the
parameters: useBrainLists, useBloodAtlases, useStem-
CellLists, useBrainRegionMarkers, usePalazzoloWang,
useImmunePathwayLists. For Gene Ontology and Gene-
Concept Network visualization, Clusterprofiler with the
enrichplot package were used. All analyses were per-
formed in R.
Western blotting
Cells were scraped in 500 μL of lysis buffer (1% Triton
X-100, 50 mM Tris-HCl, 150 mM NaCl, 5 mM EDTA,
and protease inhibitor cocktail). The total protein con-
centration was determined using a BioRad DC-protein
assay and BSA as standard according to manufacturer’s
instructions. Cell lysates (20 μg) were loaded onto a
7.5% SDS-polyacrylamide gel. After gel electrophoresis,
proteins were transferred onto polyvinylidene fluoride
(PVDF) membranes (Immobilon-FL, Merck Millipore)
by wet transfer. PVDF membranes were blocked for 1 h
with Odyssey blocking buffer (Li-Cor Biosciences), and
incubated overnight with primary antibodies against
GFAP (anti-GFAP, polyclonal, 1:5000, Dako, Z033430)
at 4 °C. After washing with PBS containing 1% Tween-
20, membranes were incubated with IRDye-conjugated
secondary antibodies (Li-Cor Biosciences, Lincoln; 1:
3000) for 1 h. As loading control, β-actin (monoclonal
mouse anti-β-actin, 1:2000, Sigma, A5441) was used.
The membranes were scanned using the Odyssey Im-
aging System (Li-Cor), and analyzed by densitometry
using FIJI ImageJ (NIH).
Immunocytochemistry
Primary cells
Live and fixed immunostainings were performed as de-
scribed [54]. For live cell immunolabelling, non-specific
antibody binding was blocked with 4% BSA for 10 min
at 4 °C, followed by incubation of the cells with A2B5
antibody (1:5, kind gift of Dr. Thijs Lopez-Cardozo, Ut-
recht, the Netherlands) for 30 min at 4 °C. Cells were
rinsed twice with PBS and incubated with appropriate
Alexa-conjugated antibody (1:500, Millipore) for 25 min
at 4 °C. After two washes with PBS, cells were fixed with
4% paraformaldehyde (PFA) in PBS for 20 min at room
temperature and incubated for 15 min with 1 μg/mL
DAPI (Sigma) to counterstain nuclei. For staining of in-
ternal antigens, PFA-fixed cells were permeabilized with
ice-cold methanol for 10 min. Non-specific antibody
binding was blocked with 4% BSA for 30 min after
which cells were incubated with either anti-Ki67 (1 μg/
mL, Abcam, ab15580) or anti-myelin basic protein
(MBP, 1:250, Serotec, MCA409S) antibodies at room
temperature. Cells were washed three times with PBS
before the appropriate Alexa-conjugated antibodies (1:
500, Millipore) were added together with 1 μg/mL DAPI
for 30 min at room temperature. After washing with
PBS, cells were mounted with mounting medium
(Dako). Cells were analyzed using a conventional im-
munofluorescence microscope (Leica DMI 6000 B)
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equipped with Leica Application Suite Advanced Fluor-
escence software. In each independent experiment, for
each condition, 15 random images were acquired result-
ing in the analysis of 150–250 cells per condition. Prolif-
eration was defined as the percentage Ki67-positive of
A2B5-positive cells, differentiation as the percentage of
MBP-positive cells of DAPI-stained cells, and myelin
membrane formation as the percentage of MBP-positive
cells that elaborate myelin membranes irrespective of
the extent of the membrane. Notably, myelin mem-
branes are membranous structures spread between cellu-
lar processes.
Spinal cord cultures
Spinal cord cultures were fixed with 4% PFA for 30 min,
followed by blocking and permeabilization with 0.1%
Triton X-100 in 4% BSA in PBS for 45 min. Cells were
washed thrice with PBS and incubated with anti-MBP
antibody (1:250) and anti-neurofilament-H (NF, poly-
clonal chicken anti-neurofilament, 1:5000, EnCor Bio-
technology Inc., 2796-7) for 90 min at room
temperature. After washing twice with PBS, cultures
were incubated with appropriate FITC- or TRITC-con-
jugated secondary antibodies (1:50, Jackson Immunola-
boratories) combined with DAPI for 45 min at room
temperature. Coverslips were mounted and cultures
were analyzed by confocal microscopy (SP8 AOBS
Microscope, Leica Microsystems) using Leica Confocal
Software. The percentage of myelinated axons was calcu-
lated in ImageJ as an area in pixels in each image occu-
pied by both myelin and axons dived by the axonal
density as described [56, 57]. In each experiment, 5 im-
ages per coverslip and 2 coverslips per condition were
analyzed.
Metabolic activity and cytotoxicity
Metabolic activity of cells was assessed by 3-(4,5-di-
methyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium brom-
ide (MTT; Sigma)-reduction, while cytotoxicity was
analyzed with a lactate dehydrogenase (LDH; Roche)
assay. For the MTT-reduction assay, 500 μg/mL MTT
was added to each well and left to incubate for 4 h at 37
°C. Cells were resuspended in dimethylsulfoxide and ab-
sorption was measured at 570 nm. Data represent values
relative to control. LDH assays were performed accord-
ing to manufacturer’s instructions using the medium of
the cells from the MTT-reduction assay and related to
LDH in medium of lysed untreated cells.
Statistics
Data are expressed as mean ± standard error of the
mean (SEM) for at least three independent experiments.
When relative values of groups were compared to NCM,
no ECM, control ACM, or control ECM coatings,
statistical analysis was performed with a one-sample t
test by setting the untreated control values at 1 in each
independent experiment. In all cases, p values of < 0.05,
< 0.01, and < 0.001 were considered significant and indi-
cated with *, **, and ***, respectively. When values
between two groups of the same cell culture prepara-
tions (wmACM versus gmACM and wmECM ver-
sus gmECM) were compared, statistical significance was
assessed using a paired two-sided t test. When values be-
tween treatment of gmASTRs or wmASTRs on OPC be-
havior were compared, an unpaired two-sided t test was
used to assess statistical significance. Here, p values of <
0.05, < 0.01, and <v0.001 were considered significant and
indicated with #, ##, and ###, respectively. Statistics were
performed using GraphPad Prism 6.0. In heatmaps of
RNAseq data FDR-values of < 0.05, < 0.01, and < 0.001
were considered significant and indicated with *, **, ***.
Results
Primary adult wmASTRs and gmASTRs are
transcriptionally heterogeneous
Previous findings indicate that remyelination is more ef-
ficient in GM lesions than in WM lesions [37, 38, 40,
41]. OLGs depend on support from ASTRs to remyeli-
nate denuded axons [4–8], and as gmASTRs and
wmASTRs are morphologically and functionally different
[27, 28, 31, 32], we aimed to address whether gmASTRs
and wmASTRs distinctly modulate myelination. As cul-
tured neonatal gmASTRs are still considered as (react-
ive) ASTR progenitors [58, 59], we used an in vitro
culture model of ASTRs derived from young adult rat
brains [51]. These primary ASTRs exhibit properties like
the expression of ASTR markers, glutamate uptake, and
responses to injury, that represent their properties in the
adult brain [51]. To assess whether primary adult
gmASTRs and wmASTRs differ, the transcriptional
profiles of ASTRs from the cerebral cortex (GM, re-
ferred to as gmASTRs) and non-cortical brain regions
(mainly WM, referred to as wmASTRs, but including
some deep gmASTRs) were compared after 20 days in
culture (Fig. 1a). Analysis of CNS cell type-specific gene
expression revealed a high abundance of transcripts of
most ASTR-specific genes (e.g., Vim, Mfeg8, Gja1), and
relatively low expression of OPC- (e.g., Cspg4, Pdgra),
newly formed OLG- (e.g., Enpp6), and mature OLG-
specific (e.g., Mbp, Mog) genes. Genes typically
expressed by microglia (e.g. Irf8, Af1, Ncf1), endothelial
cells (e.g., Cldn5, Egfl7, Vwa1), and neurons (e.g., Tubb3,
Reln, Trp73) also have a low abundance (Fig. 1b). These
data indicate that both adult gmASTRs and wmASTRs
cultures consisted of highly pure astrocytes. Principal
component analysis (PCA) indicated that 74% of the
variance between the samples was explained by region of
origin of the ASTRs (Fig. 1c), indicating that primary
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Fig. 1 (See legend on next page.)
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adult gmASTR and wmASTRs were transcriptionally dif-
ferent. Between gmASTR and wmASTRs, 857 genes
were differentially expressed (FDR < 0.01), and 183 genes
with a logFC > 2. Of these genes, 75 genes were more
abundantly expressed in gmASTRs (additional file 1)
and 108 genes in wmASTRs (additional file 1). Genes
that were more abundantly expressed in wmASTRs in-
clude several ECM-related genes (Fbln2, Eln, Postn,
Itga1), while in gmASTRs, genes involved in lipogenesis
(Scd, Scd2) and Wnt signaling (Rspo2, Wnt16) were
more abundantly expressed. Strikingly, two different
members of the cadherin family are opposingly differen-
tially expressed; Cdh2 encoding for N-cadherin was
more abundantly expressed in wmASTRs, while tran-
scripts for Cdh1 encoding for E-cadherin were more
present in gmASTRs (Fig. 1d). We next compared the
transcription profiles with the list of marker genes char-
acteristic for reactive ASTRs in general (pan-reactive
genes) and marker genes for neurotoxic A1-ASTRs and
neuroprotective A2-ASTRs as defined by Liddelow et al
[22]. Most pan-reactive ASTR marker genes were more
abundantly expressed in primary adult wmASTRs than
in primary adult gmASTRs (Fig. 1e, Lcn2, FDR = 0.021;
Gfap, Timp1, and Hsbp1 FDR < 0.001). Notably, tran-
script levels for some A1-ASTR-associated genes were
more present in wmASTRs (Ggta1 FDR = 0.002; Fbln5
FDR = 0.005; Ugt1a FDR = 0.008), while transcripts of
two A2-ASTR-associated genes (S100a10 and Emp1
FDR < 0.001) were more abundant in gmASTRs (Fig. 1e).
Although Gfap mRNA expression was relatively low in
both types of ASTRs, GFAP protein was present at de-
tectable levels (Fig. 1f). Consistent with Gfap mRNA
levels (Fig. 1e), GFAP protein levels were significantly
higher in wmASTRs compared to gmASTRs (Fig. 1g),
most likely due the low expression of a GFAP splice
variant by gmASTRs (Fig. 1f). Notably, although previ-
ous profiling studies demonstrated that primary neonatal
gmASTRs cultured in the presence of serum induces the
expression of a specific set of genes [59], none of these
serum-induced genes were expressed by our primary
adult ASTRs. Hence, primary adult wmASTRs and
gmASTRs were heterogeneous at the transcription level
even upon prolonged time in culture. To assess whether
gmASTRs and wmASTRs distinctly modulate myelin-
ation efficiency, their ability to regulate in vitro myelin-
ation was examined next.
Primary adult wmASTRs are less supportive to
myelination than primary adult gmASTRs
To study the role of gmASTRs and wmASTRs in mye-
lination efficiency, we made use of an in vitro myelinat-
ing system of total embryonic spinal cord cultures that
only develop on an ASTR feeding layer [57]. Myelination
efficiency was assessed by double labeling of myelin and
neurons, using myelin basic protein (MBP) as a marker
for myelin, and neurofilament-H (NF) as a marker for
neurons. While the axonal density was not significantly
different (gmASTRs 8.3 ± 2.4%, wmASTRs 7.1 ± 1.2%),
the percentage of myelinated axons was higher on a
feeding layer of gmASTRs than on a feeding layer of
wmASTRs (Fig. 2a, b, p = 0.016). This difference in their
ability to support in vitro myelination is either a result
of wmASTR-derived myelination-inhibiting or gmASTR-
derived myelination-stimulating signals. ASTRs can sig-
nal to OPCs via secreted soluble factors, such as growth
factors and cytokines, via insoluble factors, such as ECM
proteins, and via adhesive interactions. The transcrip-
tional profiles uncovered that wmASTRs expressed more
transcripts of both positive and negative regulators of
OPC proliferation (Pdgfra, Fgf2 [52, 60, 61]) and OPC
maturation (Bmp4, Cntf, Timp1, Fn, Vcan, Tnc, Jag1,
Igf1, Gja1, Tgm2 [62–71]) than gmASTRs (Fig. 2c). To
determine whether wmASTRs and gmASTRs differen-
tially support OPC behavior by a difference in secreted
factors, the effect of ASTR-conditioned medium (ACM)
of either ASTR on OPC proliferation, metabolic activity,
(See figure on previous page.)
Fig. 1 Primary adult wmASTRs and gmASTRs are transcriptionally heterogeneous. RNA from six independent cell culture preparations of adult
grey matter astrocytes (gmASTRs) and adult white matter ASTRs (wmASTRs), was subjected to 3′-RNA sequencing. a Schematic representation of
the dissected areas. b Heatmap of the logarithm of the gene count per million counts + 1 (log(CPM+1)) of genes specific for ASTRs, microglia
(micro), endothelial cells (endo), neurons (neuron), oligodendrocyte progenitor cells (OPCs), newly formed oligodendrocytes (nfOLGs)-, and
mature oligodendrocytes (mOLGs). Row Z-score represents relative expression of cell type-specific genes compared to each other within one
biological sample. Genes with a CPM > 20 are depicted in bold. Note that most ASTR genes are highly expressed within different batches
compared to other cell type-specific genes. c Principal component analysis (PCA) indicates that 74% of the variation between the samples is
explained by their regional origin. d A volcano plot displaying all genes. The white dots depict genes more abundantly expressed in wmASTRs,
and grey dots display genes more abundantly expressed in gmASTRs (absolute logarithm of fold change (logFC) > 2, FDR < 0.01). The small black
dots are all remaining genes that are identified but not differentially expressed. e Heatmap of pan-reactive-, A1-, and A2-specific ASTR markers.
Column Z-score represents the relative expression of genes between different samples. Genes with a CPM > 20 are depicted in bold (*FDR < 0.05,
**FDR < 0.01, ***FDR < 0.001). Note that several pan-reactive and A1-ASTR-specific genes are more expressed in wmASTRs, while some A2-ASTR-
specific genes are more expressed in gmASTRs. f, g Western blot analysis of GFAP. A representative image is shown in f, and quantification of
three independent ASTR culture preparations (black dots) in g. Bars represent the relative mean to wmASTRs, which were set to 1 in each
independent experiment. Error bar indicates the standard error of the mean. Statistical analyses are performed using column statistics with a one-
sample t test (*p < 0.05) to assess differences between gmASTRs and wmASTRs. Note that GFAP expression is higher in wmASTRs (p = 0.038)
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and/or maturation was examined (Fig. 3a–c). OPC pro-
liferation, as assessed by the number of Ki67-positive
cells of A2B5-positive OPCs, was similar when OPCs
were exposed to gmACM, wmACM, and non-
conditioned medium (NCM) (Fig. 3d). After 6 days of
differentiation, the metabolic activity, as assessed by an
MTT assay, was increased upon exposure to gmACM
compared to both wmACM and NCM (Fig. 3d, gmACM
versus NCM p = 0.016; gmACM versus wmACM p =
0.033). Remarkably, ACM from neither ASTR was toxic
to the cells (Fig. 3d), despite wmASTRs more abundantly
expressing specific genes for neurotoxic A1-ASTRs
(Fig. 1e). In addition, while the percentage of MBP-
positive OLGs, reflecting their differentiation, remained
similar, the percentage of MBP-positive OLGs that elab-
orate myelin membranes was significantly decreased in
the presence of wmACM compared to NCM (Fig. 3c, d,
p = 0.005). Exposure to gmACM did not affect OPC dif-
ferentiation or myelin membrane formation (Fig. 3d). To
examine the effect of ASTR-derived ECM on OPC be-
havior, OPCs were cultured on coatings of gmECM or
wmECM. OPC proliferation was significantly increased
when OPCs were plated on a gmECM coating compared
to an inert PLL-coating (no ECM, Fig. 3e, f, p = 0.041).
OPC proliferation was not affected by a wmECM coating
(Fig. 3d–f). OPC differentiation and myelin membrane
formation were not altered when plated on either
gmECM or wmECM coatings compared to a PLL-
coating (Fig. 3f). Hence, these findings revealed that
wmASTRs were less supportive to in vitro myelination
than gmASTRs, which may be the result of an inhibitory
effect of wmASTR-derived secreted factor(s) that
preclude myelin membrane formation and/or a stimula-
tory effect of gmASTR-deposited ECM on OPC prolifer-
ation. To obtain more insight into the gene networks
that drive the distinct regulation of myelination by
gmASTRs and wmASTRs, a weighted gene co-
expression network analysis (WGCNA) was performed.
Gene co-expression networks differ between primary
adult wmASTRs and gmASTRs
WGCNA is a powerful method that determines corre-
lated changes in gene expression allowing for the identi-
fication of modules of similarly expressed gene networks
that represent biological functions and regulatory mech-
anisms [72]. WGCNA analysis identified 14 modules of
highly connected genes with similar expression pattern
(Fig. S1a, b, additional file 2). The correlation between
each Module Eigengene (ME) and the trait region
(gmASTRs and wmASTRs) revealed that the MEroyal-
blue and MEdarkgrey modules were significantly and
differentially correlated with region across the biological
replicates of gmASTR and wmASTR cell culture prepa-
rations (Fig. S1b-d, additional file 2). Module MEroyal-
blue, consisting of 844 genes, was positively correlated
with gmASTRs (p < 0.001) and negatively correlated
with wmASTRs (Fig. S1b, c, additional file 2). To re-
trieve the biological processes the genes of this module
are involved in, gene ontology (GO) annotation analysis
was performed. Many genes represented in the MEroyal-
blue module were related to “cell division” (Fig. 4a).
Additionally, genes that are enriched in the MEroyalblue
module were related to GO terms “sterol biosynthetic
process,” “steroid biosynthetic process,” “cholesterol
Fig. 2 WmASTRs are less supportive to in vitro myelination. a, b In vitro myelination cultures that depend on a feeding layer of astrocytes (ASTRs)
are stained for myelin basic protein (MBP, green) and neurofilament-H (NF, red), a myelin and axonal marker, respectively. Representative images
of myelinating cultures on either adult white matter (wm) ASTRs or adult grey matter (gm) ASTRs are shown in a and quantification of the
percentage of myelinated axons of four independent culture preparations and four independent ASTR culture preparations (black dots) in b. Bars
represent the % of myelinated axons. Error bars represent standard error of the mean. Note that less axons are myelinated on a feeding layer of
wmASTRs than on a feeding layer of gmASTRs. Scale bar is 25 μm. c RNA from six independent cell culture preparations of adult gmASTRs and
wmASTRs was subjected to 3′-RNA sequencing. Heatmap with literature-based genes of positive and negative regulators of OPC proliferation and
differentiation by gmASTRs and wmASTRs is shown. Column Z-score represents the relative expression of genes between different samples.
Positive regulators of OPC differentiation are indicated in green; negative regulators in red (*FDR < 0.05, **FDR < 0.01, ***FDR < 0.001).
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biosynthetic process,” and “secondary alcohol biosyn-
thetic process” (Fig. 4a). An interaction network of the
genes in these biosynthetic processes demonstrated that
some of these genes are shared between multiple GO
terms (Fig. 4b). A heatmap of relevant sterol, steroid,
and cholesterol biosynthesis genes (Fig. S2, additional
Fig. 3 Secreted factors from wmASTRs inhibit myelin membrane formation. a–f Oligodendrocyte progenitors cells (OPCs) were cultured with
PDGF-AA and FGF2 for 24 h to assess proliferation (% Ki67-positive cells of A2B5-positive cells, schematic representation in a), or differentiated
into mature oligodendrocytes (OLGs) for 6 days after growth factor withdrawal to assess metabolic activity (MTT), cytotoxicity (LDH),
differentiation (% MBP-positive cells), and myelin membrane formation (% myelin membranes formed by MBP-positive cells) (schematic
representation in b). Assays were performed in the presence or absence of astrocyte (ASTR)-conditioned medium (ACM) or ASTR-derived
extracellular matrix (ECM) coatings obtained from primary adult grey matter (gm) or white matter (wm) ASTRs. Representative images of MBP-
positive OLGs (red, arrow indicates a MBP-positive cell with myelin membrane, arrowhead a MBP-positive cell without myelin membrane) in the
presence of non-conditioned medium (NCM) or ACM are shown in c; representative images of proliferation on no ECM (PLL) or ECM coatings
stained for Ki67 (red) and A2B5 (black) are shown in d. Quantification of assays of 4–12 independent cell culture preparations (black dots) with 4–
12 different batches of ACM (e) and ECM coatings (f) are shown. Bars represent the relative means to NCM (e) or no ECM (f), which were set to 1
in each independent experiment. Error bars indicate the standard error of the mean. Statistical analyses are performed using column statistics
with a one-sample t test (*p < 0.05) to assess differences between treatments and control, while a paired two-sided t test (*p < 0.05) is used to
examine differences between effects of gmACM or gmECM coatings versus respectively wmACM or wmECM coatings. Absolute values of NCM
are for proliferation 37.5 ± 22.4%, cytotoxicity 25.9 ± 2.9%, differentiation 48.6 ± 17.6%, and myelin membrane formation 68.0 ± 14.4% and of no
ECM for proliferation 17.8 ± 4.8%, differentiation 33.3 ± 4.7%, and myelin membrane formation 65.3 ± 3.8%. Note that upon exposure to wmACM,
myelin membrane formation is decreased compared to NCM (p = 0.005), while metabolic activity is increased upon gmACM treatment compared
to NCM (*p = 0.016) and wmACM treatment (#p = 0.033) (c, d). In addition, OPC proliferation is higher on gmECM coatings than on no ECM (p =
0.041) (e, f). Scale bars are 25 μm
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file 3) illustrates a higher expression of these genes in
gmASTRs than in wmASTRs, which predicts that
there is more cholesterol biosynthesis in primary
adult gmASTRs. Notably, ASTRs supply cholesterol to
OLGs, which supports myelination [4, 7, 73].
The other significantly different module, MEdarkgrey,
consists of 1110 genes and positively correlated with
wmASTRs (p < 0.001) and negatively with gmASTRs (Fig.
S1b, d, additional file 2). GO terms related to this module
included processes as “ECM formation and modification,”
“atherosclerosis,” “hypoxia,” and “vascularization” (Fig. 4c).
Of interest, transient ECM remodeling plays an important
role in successful remyelination [5, 57, 74, 75]. The extra-
cellular matrix proteome, or the “matrisome” consists of
core and associated proteins [76] and a heatmap of abun-
dantly expressed matrisome-core and matrisome-
associated genes that differed significantly (FDR < 0.05)
(Fig. 4d) illustrates that these genes are more abundantly
Fig. 4 Gene co-expression networks differ between primary adult wmASTRs and gmASTRs. RNA from six independent cell culture preparations of
adult grey matter astrocytes (gmASTRs) and adult white matter ASTRs (wmASTRs) was subjected to 3′-RNA sequencing. A weighted gene co-
expression network analysis revealed that the MEroyalblue module positively correlated with gmASTRs and negatively with wmASTRs and that
the MEdarkgrey module negatively correlated with gmASTRs and positively with wmASTRs (Fig. S1, Additional file 2). a Gene ontology (GO)
annotation of the genes in the MEroyalblue module visualized in a dot plot. The color of the dot represents the enrichment score (p value), the
size of the dot the gene count. Note that genes related to functions as “cell division” and “cholesterol biosynthesis” are enriched in the
MEroyalblue module. b Visualization of the interaction network of the genes present in the four indicated GO categories (black dots) from the
MEroyalblue cluster. Note that some genes are shared between different GO terms. c GO annotation of the genes in the MEdarkgrey module
visualized in a dot plot. The color of the dot represents the enrichment score (p value), the size of the dot the gene count. Note that genes
related to functions as “response to hypoxia” “extracellular matrix organization” are enriched int the MEdarkgrey module. d Heatmap of the
extracellular matrix proteome or “matrisome”-core and -associated genes with a CPM > 20, an absolute logFC > 2, and an FDR < 0.05 by gmASTRs
and wmASTRs. Column Z-score represents the relative expression of genes between different samples. Note that more genes encoding for
matrisome-core and -associated genes are more abundantly expressed in wmASTRs (*FDR < 0.05, **FDR < 0.01, ***FDR < 0.001)
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expressed in wmASTRs than in gmASTRs. These more
abundant genes encode for ECM-core proteins (e.g.,
Mfeg8, Ctgf, Spp1, Ltbp1) that are mainly matricellular
proteins, and ECM-affiliated proteins (e.g., Bdnf, Hbegf,
Mmp12, Ccl2, Ccl7), which are proteins that regulate
ECM remodeling or secreted factors that associated with
the ECM. Notably, transcripts of Sema3f, an OPC attract-
ant, were more present in gmASTRs than in wmASTRs
(Fig. 4d). Several ECM genes that were more abundantly
expressed in primary adult wmASTRs were associated
with pathways previously implicated in OPC maturation
and/or remyelination failure (Ctgf, Tnc, Spp1 [21, 67, 77–
79]) and/or expressed in reactive ASTRs in WM MS le-
sions (Mfeg8, Tnc, Spp1 [34, 77, 80, 81]), and may relate to
the more reactive ASTR profile of primary adult
wmASTRs (Fig. 1). Hence, the regulatory mechanisms
that may account for the higher in vitro myelination po-
tential of OLGs in the presence of gmASTRs, are more
cholesterol biosynthesis in gmASTRs and increased de-
position of matrisome constituents by wmASTRs. The dif-
ferent identities of gmASTRs and wmASTRs may result in
distinct and specific responses toward inflammatory medi-
ators that are increased upon injury. As demyelination in-
volves innate immune activation, and as TLR3 and TLR4
are prominently present on reactive ASTRs in WMMS le-
sions [13, 49], we next examined whether gmASTRs and
wmASTRs may respond differently to TLR3 and/or TLR4
agonists and as a consequence distinctly modulate OPC
behavior.
Adult gmASTRs and wmASTRs responding to TLR4
agonist LPS decrease myelin membrane formation
As TLR3 and TLR4 agonists interfered with the develop-
ment of neurons, OPCs, and OLGs in the in vitro myeli-
nating cultures, we were not able to examine the role of
ASTR reactivity on in vitro myelination. Therefore, to
assess whether gmASTRs and wmASTRs differently re-
spond to TLR4 ligands, the effect of TLR4 agonist LPS
on primary ASTRs and their ability to modulate OPC
behavior via secreted factors (ACM) or coatings of de-
posited ECM components was determined. Secreted fac-
tors from LPS-treated wmASTRs and gmASTRs did not
significantly change OPC proliferation (Fig. 5a) and
differentiation (Fig. 5c). Secreted factors from both LPS-
treated gmASTRs and wmASTRs markedly inhibited
myelin membrane formation by 40–50% compared to
secreted factors from their respective untreated ASTRs
(Fig. 5d, gmACM p = 0.020, wmACM p = 0.003). This is
accompanied by a significant decrease in metabolic ac-
tivity by 30–40% upon wmACM treatment (Fig. 5b
wmACM p = 0.039), and a reproducible, but not signifi-
cant decrease upon gmACM treatment (Fig. 5b). ECM
coatings of LPS-treated gmASTRs or wmASTRs did not
significantly alter OPC proliferation (Fig. 5a),
differentiation (Fig. 5b), or myelin membrane formation
(Fig. 5c). Hence, our findings demonstrate that LPS-
treated wmASTRs and gmASTRs similarly modulate
OPC behavior by secreting factors that reduced the per-
centage of MBP-positive OLGs that form myelin
membranes.
Adult gmASTRs and wmASTRs responding to TLR3
agonist Poly(I:C) distinctly modulate OPC proliferation
and myelin membrane formation
To assess whether gmASTRs and wmASTRs differently
respond to TLR3 ligands, the effect of TLR3 agonist
Poly(I:C) on ASTRs, and their ability to modulate OPC
behavior was determined next. Secreted factors from
Poly(I:C)-treated wmASTRs, but not from Poly(I:C)-
treated gmASTRs, decreased OPC proliferation by ap-
proximately 18% compared to their respective untreated
control ASTRs (Fig. 6a, p = 0.027). In contrast, OPC
proliferation was increased when plated on ECM coat-
ings of Poly(I:C)-treated wmASTRs compared to ECM
coatings of untreated control wmASTRs (Fig. 6a, p =
0.012) and ECM coatings of Poly(I:C)-treated gmASTRs
(Fig. 6a, p = 0.002). ACM of Poly(I:C)-treated gmASTRs
reproducibly and significantly reduced myelin membrane
formation by approx. 20% compared to untreated
gmACM (Fig. 6d, p = 0.016). By contrast, myelin mem-
brane formation was unchanged when OPCs were ex-
posed to ACM of Poly(I:C)-treated wmASTRs (Fig. 5d).
Secreted factors or ECM coatings from Poly(I:C)-treated
gmASTRs or wmASTRs hardly affected the metabolic
activity of OLGs and OPC differentiation compared to
secreted factors or ECM coatings from their respective
untreated control ASTRs (Fig. 6b, c). These data demon-
strate that Poly(I:C) treatment of primary adult gmASTR
and wmASTRs results in a modest but distinct
modulation of OPC proliferation and myelin membrane
formation. As secreted factors from Poly(I:C)-treated
gmASTRs reduced myelin membrane formation, this
may indicate that Poly(I:C)-treated gmASTRs are less
supportive to myelination than untreated gmASTRs.
Discussion
ASTRs support myelination during development and are
indispensable for successful remyelination upon demye-
lination [2, 3, 17]. As remyelination is more efficient in
GM lesions than in WM (MS) lesions [37, 38, 40, 41,
82], we aimed here to address whether the distinct
modulation of myelination is a reflection of heterogen-
eity between gmASTRs and wmASTRs. Our findings
demonstrate that primary adult wmASTRs were less
supportive toward in vitro myelination than primary
adult gmASTRs. Transcriptional profiling demonstrated
that even after prolonged time in culture, adult
gmASTRs and adult wmASTRs have a distinct
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transcriptional profile, which may underlie their differ-
ence in modulating in vitro myelination. Moreover,
when exposed to TLR4 agonist LPS, secreted factors of
both gmASTRs and wmASTRs markedly inhibited mye-
lin membrane formation, while TLR3 agonist Poly(I:C)-
treated gmASTRs and wmASTRs elicited modest but
distinct responses in OPC proliferation and myelin
membrane formation. Hence, our findings indicate that
pre-existing regional heterogeneity in ASTRs may con-
tribute to differences in remyelination efficiency in
demyelinated GM and WM.
Our findings demonstrate that more axons were mye-
linated on a feeding layer of primary adult gmASTRs
than on a feeding layer of primary adult wmASTRs. As
Fig. 5 Secreted factors from primary adult ASTRs responding to TLR4 agonist LPS decrease myelin membrane formation. a–d Primary adult grey
matter astrocytes (gmASTRs) and white matter ASTRs (wmASTRs) were cultured for 24 h in the presence or absence of TLR4 agonist LPS, after
which conditioned medium (ACM) was collected in the next 24 h. For extracellular matrix proteins (ECM), ASTRs were cultured for 48 h in the
presence or absence of LPS after which the cells were lysed, ECM was collected, and used as a coating. Oligodendrocyte progenitor cells (OPCs)
were cultured in the presence of ACM or on ECM coatings, for 1 day in the presence of PDGF-AA and FGF-2 to assess proliferation (a, % Ki67-
positive cells of A2B5-positive cells), or differentiated for six 6 days after growth factor withdrawal to assess metabolic activity (b, MTT),
differentiation (c, % MBP-positive cells of total cells), and myelin membrane formation (d, % myelin membranes formed by MBP-positive cells).
Bars represent relative means to their respective untreated control ACM or ECM coatings, which were set to 1 in each independent experiment.
Individual data points (black dots) represent independent OPC culture preparations with three to five different batches of ACM or ECM. Error bars
indicate standard error of the mean. Statistical analyses are performed using column statistics with a one-sample t test (*p < 0.05) to assess
differences with untreated control ACM or ECM coatings and with an unpaired two-sided t test (not significant) to assess differences between
response to ACM or ECM coatings of LPS-treated gmASTRs compared to ACM or ECM coatings of LPS-treated wmASTRs. Absolute values are 34.3
± 17.4% proliferation, 55.1 ± 19.1% differentiation, and 56.8 ± 17.7% myelin membrane formation with control wmACM; 39.6 ± 13.5%
proliferation, 61.6 ± 22.2% differentiation, and 67.4 ± 20.3% myelin membrane formation with control gmACM; 31.4 ± 12.5% proliferation, 51.9 ±
18.6% differentiation, and 56.7 ± 22.3% myelin membrane formation on control wmECM coatings and 41.0 ± 1.7% proliferation, 44.8 ± 15.1%
differentiation, and 51.5 ± 12.5% myelin membrane formation on control gmECM coatings. Note that myelin membrane formation is decreased
in the presence of ACM of both LPS-treated wmASTRs and gmASTRs (wmACM p = 0.003, gmACM p = 0.020)
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secreted factors from wmASTRs, but not gmASTRs, de-
creased membrane formation, it is tempting to suggest
that wmASTRs were less supportive to myelination. The
transcriptional data provided insight into differences in
gene expression of signaling molecules in gmASTRs and
wmASTRs that are relevant for myelination and
remyelination. Analysis of literature-based modulators of
OPC behavior revealed that wmASTRs were equipped
with higher transcript levels of genes encoding for sig-
naling molecules that either positively or negatively
modulate OPC proliferation and differentiation [52, 60,
61]. These signaling molecules were soluble (Bmp4, Fgf2,
Fig. 6 Primary adult gmASTRs and wmASTRs responding to TLR3 agonist Poly(I:C) distinctly modulate OPC behavior. a–d Primary adult grey
matter astrocytes (gmASTRs) and white matter ASTRs (wmASTRs) were cultured for 24 h in the presence or absence of TLR3 agonist Poly(I:C),
after which conditioned medium (ACM) was collected in the next 24 h. For extracellular matrix proteins (ECM), ASTRs were cultured for 48 h in
the presence or absence of Poly(I:C) after which the cells were lysed, ECM was collected and used as a coating. Oligodendrocyte progenitor cells
(OPCs) were cultured in the presence of ACM or on ECM coatings, for 1 day in the presence of PDGF-AA and FGF-2 to assess proliferation (a, %
Ki67-positive cells of A2B5-positive cells), or differentiated for six days after growth factor withdrawal to assess metabolic activity (b, MTT),
differentiation (c, % MBP-positive cells of total cells), and myelin membrane formation (d, % myelin membranes formed by MBP-positive cells).
Bars represent relative means to their respective untreated control ACM or ECM coatings, which were set to 1 in each independent experiment.
Individual data points (black dots) represent independent OPC culture preparations with three to five different batches of ACM or ECM. Error bars
indicate standard error of the mean. Statistical analyses are performed using column statistics with a one-sample t test (*p < 0.05) to assess
differences with untreated control ACM or ECM coatings, and with an unpaired two-sided t test (##p < 0.01) to assess differences between
response to ACM or ECM coatings of Poly(I:C)-treated gmASTRs and ACM or ECM coatings of Poly(:C)-treated wmASTRs Absolute values are 42.5
± 13.9% proliferation, 34.9 ± 7.6% differentiation, and 58.4 ± 9.1% myelin membrane formation with control wmACM; 38.4 ± 14.1% proliferation,
35.3 ± 12.2% differentiation, and 67.5 ± 10.1% myelin membrane formation with control gmACM; 21.6 ± 4.0% proliferation, 31.8 ± 5.7%
differentiation, and 81.1 ± 10.1% myelin membrane formation on control wmECM coatings and 31.4 ± 5.8% proliferation, 37.5 ± 5.3%
differentiation, and 75.8 ± 18.6% myelin membrane formation on control gmECM coatings. Note that OPC proliferation is decreased in the
presence of ACM of Poly(I:C)-treated wmASTRs (*p = 0.027) and increased on ECM coatings of Poly(I:C)-treated wmASTRs (*p = 0.012), but not on
ECM-coatings of gmASTRs (##p = 0.0016 compared to ECM from Poly(I:C)-treated wmASTRs), while myelin membrane formation is decreased in
the presence of ACM of Poly(I:C)-treated gmASTRs (p = 0.016)
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Cntf, Pdgfa [52, 60, 61, 64, 65]), ECM-derived (Fn1,
Vcan, Tnc, Spp1 [62, 67, 71, 75, 77]) or adhesion-
dependent (Jag1). Likely, it reflects the net effect of these
factors that made wmASTRs less supportive to myelin-
ation than gmASTRs in our in vitro myelinating culture
system. Also, wmASTRs were more reactive than
gmASTRs, and expressed more transcripts of several
A1-ASTR-specific genes, while A2-ASTRs-specific genes
were more abundantly expressed in gmASTRs. This is
consistent with a recent single-nucleus RNA sequencing
study of human control brain tissue that demonstrated
transcriptional heterogeneity between human gmASTRs
and wmASTRs [29], including a more reactive profile of
wmASTRs compared to gmASTRs [29]. Hence, our pri-
mary adult gmASTRs and wmASTRs maintain some
properties that are also observed in GM and WM areas.
In addition to wmASTRs being less supportive,
gmASTRs may promote in vitro myelination. ECM
components deposited by gmASTRs increased OPC pro-
liferation, and as a higher density of OPCs augments
myelination [83], enhanced proliferation may contribute
to the increased in vitro myelination on gmASTRs. Also,
an unbiased gene co-expression network analysis identi-
fied a gene module, which positively correlated with
gmASTRs and negatively with wmASTRs that contained
genes relevant to cell division and cholesterol biosyn-
thesis. Cholesterol is a major constituent of myelin
membranes [7], and in the adult brain mainly synthe-
sized by ASTRs [4, 84]. Cholesterol enhances OPC dif-
ferentiation [7, 73] and is the only known indispensable
integral lipid in myelin of which its availability is rate-
limiting for myelin growth [7]. Therefore, gmASTRs
may supply more cholesterol to developing OLGs,
which benefits myelination [4, 7, 73, 85]. Indeed, we
recently demonstrated that neonatal gmASTRs efflux
more cholesterol than neonatal wmASTRs [85]. Also,
genes involved in cholesterol biosynthesis are down-
regulated in MS wmASTRs compared to ASTRs in
healthy control WM [33], which may limit remyelina-
tion in WM lesions.
WGCNA further revealed that a gene module contain-
ing genes encoding for proteins that are relevant for
ECM production and modification, i.e., the matrisome
[86] was significantly correlated with wmASTRs. ASTRs
are known to play an essential role in transient ECM re-
modeling, which is important for successful remyelina-
tion upon toxin-induced demyelination [75, 87–89]. In
addition, increased expression of ECM proteins usually
marks ASTR reactivity [12, 90]. Therefore, the enhanced
expression of genes that are related to the matrisome is
likely part of the more reactive phenotype of wmASTRs.
Most of the matrisome-core enriched genes were matri-
cellular proteins (Thbs2, Postn, Ctgf, Fbln2, Spp1), which
are non-structural ECM proteins that support matrix
fibrillogenesis and/or that have important functions in
tissue repair [91]. These proteins may both influence
matrix formation and signals to OPCs by modulating
cell functioning via interaction with cell-surface recep-
tors and structural ECM proteins, such as fibronectin
and proteoglycans that are present in demyelinated areas
[75, 88]. Thus, the effect of ECM coatings on OPC be-
havior presented in the present study are likely underes-
timated, as ECM coatings do not reflect all properties of
the ECM, such as the original topological ECM architec-
ture and stiffness. Indeed, the stiffness of the ECM influ-
ences OPC behavior; a stiff matrix favors OPC
proliferation and initial differentiation and myelination
is supported by a relatively soft matrix [6]. Hence, a
higher abundance of ECM-related genes in wmASTRs
may contribute to less efficient remyelination in WM le-
sions compared to GM lesions. This is indeed observed
in leukocortical MS lesions, where ECM protein hyalur-
onan, an inhibitor of OPC differentiation [92], and its re-
ceptor CD44, are significantly increased in the WM, but
not in the GM part of leukocortical lesions [41]. Also,
wmASTRs form more remyelination-impairing fibronec-
tin aggregates than gmASTRs [93], and fibronectin ex-
pression is increased in marmoset EAE WM, but not
GM lesions [94]. Thus, interference with the wmASTR-
mediated role in ECM remodeling may prove a valuable
target for the enhancement of remyelination in WM MS
lesions.
Diversity between wmASTRs and gmASTRs was also
observed in their modulation of OPC behavior in re-
sponse to TLR3 agonist Poly(I:C). More specifically, se-
creted factors of Poly(I:C)-treated gmASTRs, but not of
Poly(I:C)-treated wmASTRs, decreased myelin mem-
brane formation compared to secreted factors from their
respective untreated ASTRs. Previous studies revealed
that exposure to Poly(I:C) in rodent ASTRs induced the
expression of both pro-inflammatory mediators that are
linked to A1-ASTRs, and inflammatory mediators that
are secreted by A2-ASTRs [22, 95]. In line with this rea-
soning, Poly(I:C) may distinctly interfere with gmASTR
and wmASTR reactive subtypes. ASTR reactivity is also
reflected in alterations in ECM remodeling, and OPC
proliferation in response to ECM coatings of Poly(I:C)-
treated wmASTRs significantly differed from ECM
coatings of Poly(I:C)-treated gmASTRs. Thus, intrinsic
differences between gmASTRs and wmASTRs may
control remyelination differently by reacting in a region-
specific manner to demyelinating injury. This is consist-
ent with changes in gene expression between ASTRs
from different regions in an animal model for MS [33],
as well as differential responses of ASTRs isolated from
different regions in vitro [32]. On the other hand, se-
creted factors from both TLR4 agonist LPS-treated
gmASTRs and wmASTRs reduced myelin membrane
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formation. Therefore, the ASTR responses in GM and
WM lesions may not only depend on the pre-existing
heterogeneity of gmASTRs and wmASTRs and their
differential response to the same type of inflammatory
mediator, but may also relate to the local inflamma-
tory context, which is different in GM and WM
lesions [19, 41, 46, 96, 97].
Conclusions
Taken together, primary adult gmASTRs and wmASTRs
are diverse cell types, and heterogeneous at the tran-
scriptional and GFAP protein level. They differ in their
ability to modulate in vitro myelination and in their re-
sponse to TLR3 agonists. As wmASTRs are intrinsically
more reactive and less supportive to in vitro myelination,
this may contribute to the more efficient remyelination
observed in GM lesions compared to WM lesions. Iden-
tification of secreted or ECM-related factors that differ-
entially modulate remyelination efficiency may identify
new region-specific ASTR-targeted therapies for MS. In
addition, validation of therapeutic tools for remyelina-
tion should take potential differences between gmASTRs
and wmASTRs into account.
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